---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-044346"
form_type: "8-K"
ticker: "AIXC"
cik: "0001460702"
company_name: "AIxCrypto Holdings, Inc."
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:46:05.944143+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Qualigen Therapeutics effects 1-for-50 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse stock split at 1:50 ratio effective 12:01 a.m. ET on November 5, 2024.
- Reduces outstanding shares from ~36.8M to approx. 736k shares; no change in authorized shares.
- No fractional shares; cash in lieu paid at $5.055 per pre-split share (closing price on Nov 4).
- Intended to meet Nasdaq $1.00 minimum bid price requirement (Rule 5550(a)(2)).
- Trading symbol remains QLGN; CUSIP changed to 74754R 301.

## SEC filing metadata
- accession: 0001493152-24-044346
- form_type: 8-K
- ticker: AIXC
- cik: 0001460702
- company_name: AIxCrypto Holdings, Inc.
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 8.01, 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1460702/000149315224044346/0001493152-24-044346-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1460702/000149315224044346/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-044346
- JSON: https://secwatch.observer/filing/0001493152-24-044346.json
- Plain text: https://secwatch.observer/filing/0001493152-24-044346.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.